Market Comparison of Inovio Pharmaceuticals and Synlogic, Inc.
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
What happened
An independent report compared the market profiles of two small-cap healthcare companies, Inovio Pharmaceuticals and Synlogic. The comparison covered institutional and insider ownership, revenue, earnings per share, and valuation. Synlogic had higher earnings but lower revenue than Inovio Pharmaceuticals and was trading at a lower price-to-earnings ratio. Regarding risk, Synlogic had a beta of 0.5, while Inovio Pharmaceuticals had a beta of 1.63.
From themarketsdaily.com
Why it matters
The report detailed the ownership structures, noting that 63.4% of Synlogic shares were held by institutional investors compared to 26.8% of Inovio Pharmaceuticals shares. The findings provide investors with comparative data on the market risk and market capitalization profiles of both companies.
From themarketsdaily.com
Who's involved
- Inovio PharmaceuticalsAmerican biotechnology company whose market profile was compared to Synlogic.
Keep exploring
The entities involved
-
Inovio Pharmaceuticals
American biotechnology company
Nothing else this week.